Don’t miss CathWorks at ACC.23/WCC March 4–6 in New Orleans!

FFRangio System
Clinical Studies
Resources
Company
Investors
Contact

Thanks, we’ll be in touch.

Thanks for submitting your inquiry. We will get back to you soon.

Regulatory Status

The CathWorks FFRangio^® System has received United States 510(k) clearance, Israel Amar approval and Japan PMDA approval. The FFRangio System fulfills the requirements for CE marking (0344).

© 2024 CathWorks | CathWorks and FFRangio are registered trademarks of CathWorks | Privacy | Terms

MAR-000590 Rev 10

© 2024 CathWorks

CathWorks and FFRangio are registered trademarks of CathWorks

Privacy | Terms

MAR-000590 Rev 10